121 related articles for article (PubMed ID: 29563163)
21. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
22. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
23. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
[TBL] [Abstract][Full Text] [Related]
24. Effect of {beta}4 integrin knockdown by RNA interference in anaplastic thyroid carcinoma.
Noh TW; Soung YH; Kim HI; Gil HJ; Kim JM; Lee EJ; Chung J
Anticancer Res; 2010 Nov; 30(11):4485-92. PubMed ID: 21115897
[TBL] [Abstract][Full Text] [Related]
25. Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.
Maggisano V; Celano M; Lepore SM; Sponziello M; Rosignolo F; Pecce V; Verrienti A; Baldan F; Mio C; Allegri L; Maranghi M; Falcone R; Damante G; Russo D; Bulotta S
Endocrine; 2019 Mar; 63(3):545-553. PubMed ID: 30661164
[TBL] [Abstract][Full Text] [Related]
26. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression.
Wang R; Lin F; Wang X; Gao P; Dong K; Wei SH; Cheng SY; Zhang HZ
Cancer Biol Ther; 2007 Aug; 6(8):1295-301. PubMed ID: 17712228
[TBL] [Abstract][Full Text] [Related]
27. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.
Liu Y; Gunda V; Zhu X; Xu X; Wu J; Askhatova D; Farokhzad OC; Parangi S; Shi J
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7750-5. PubMed ID: 27342857
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of silencing hTERT gene by short hairpin RNA on growth of human laryngeal squamous cell carcinoma xenograft in nude mice].
Liu D; Tao ZZ; Xiao BK; Chen SM; Chi HM
Ai Zheng; 2006 Jan; 25(1):11-6. PubMed ID: 16405742
[TBL] [Abstract][Full Text] [Related]
29. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098
[TBL] [Abstract][Full Text] [Related]
30. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
31. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Tahtouh R; Azzi AS; Alaaeddine N; Chamat S; Bouharoun-Tayoun H; Wardi L; Raad I; Sarkis R; Antoun NA; Hilal G
PLoS One; 2015; 10(3):e0119512. PubMed ID: 25822740
[TBL] [Abstract][Full Text] [Related]
33. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
34. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth
Muralidharan R; Babu A; Amreddy N; Srivastava A; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
Mol Cancer Ther; 2017 Aug; 16(8):1470-1486. PubMed ID: 28572169
[TBL] [Abstract][Full Text] [Related]
35. CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.
Antonelli A; Bocci G; La Motta C; Ferrari SM; Fallahi P; Ruffilli I; Di Domenicantonio A; Fioravanti A; Sartini S; Minuto M; Piaggi S; Corti A; Alì G; Di Desidero T; Berti P; Fontanini G; Danesi R; Da Settimo F; Miccoli P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E528-36. PubMed ID: 22278419
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
[TBL] [Abstract][Full Text] [Related]
37. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
Liu L; Li H; Zhang M; Lv X
Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
[TBL] [Abstract][Full Text] [Related]
38. Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.
Park YJ; Kim EK; Moon S; Hong DP; Bae JY; Kim J
Anticancer Res; 2014 Nov; 34(11):6389-95. PubMed ID: 25368238
[TBL] [Abstract][Full Text] [Related]
39. Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer.
Sadreddini S; Safaralizadeh R; Baradaran B; Aghebati-Maleki L; Hosseinpour-Feizi MA; Shanehbandi D; Jadidi-Niaragh F; Sadreddini S; Kafil HS; Younesi V; Yousefi M
Immunol Lett; 2017 Jan; 181():79-86. PubMed ID: 27916629
[TBL] [Abstract][Full Text] [Related]
40. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
